NCT00364455View on ClinicalTrials.gov

Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

March 31, 2006

Conditions
ProstateCarcinoma
Interventions
DRUG

Epoetin alfa

All Listed Sponsors
collaborator

Ontario Clinical Oncology Group (OCOG)

OTHER

lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00364455 - Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. | Biotech Hunter | Biotech Hunter